[HTML][HTML] Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): Rationale and design of a randomized controlled trial assessing …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - Springer
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

[HTML][HTML] Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - ncbi.nlm.nih.gov
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - …, 2022 - researchinformation.amsterdamumc …
BACKGROUND: Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - research.rug.nl
Background: Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Arterial stiffness and calcification propensity
are associated with high cardiovascular risk and increased mortality in chronic kidney …

[HTML][HTML] Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing …

EA Vermeulen, C Eelderink, T Hoekstra… - …, 2022 - trialsjournal.biomedcentral.com
Arterial stiffness and calcification propensity are associated with high cardiovascular risk
and increased mortality in chronic kidney disease (CKD). Both magnesium and phosphate …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - search.proquest.com
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

E Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - europepmc.org
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects …

EA Vermeulen, C Eelderink, T Hoekstra… - Trials, 2022 - europepmc.org
Background Arterial stiffness and calcification propensity are associated with high
cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both …